Details for Patent: 8,513,259
✉ Email this page to a colleague
Which drugs does patent 8,513,259 protect, and when does it expire?
Patent 8,513,259 protects QUZYTTIR and is included in one NDA.
This patent has five patent family members in five countries.
Summary for Patent: 8,513,259
| Title: | Non-sedating antihistamine injection formulations and methods of use thereof |
| Abstract: | Described herein are injectable compositions containing non-sedating or second and third generation antihistamines such as cetirizine/levocetirizine and methods of use thereof. Specifically, methods of treating acute urticaria or angioedema associated with an acute allergic reaction are disclosed. In certain embodiments, the injectable compositions are bioequivalent to currently marketed oral dosage forms with the same number of mg of cetirizine. |
| Inventor(s): | Du; Jie (Lansdale, PA) |
| Assignee: | JDP Therapeutics, Inc. (Lansdale, PA) |
| Application Number: | 13/238,453 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,513,259
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF INCREASING PEAK PLASMA OR ONSET OF PLASMA CONCENTRATION BY INTRAVENOUS INJECTION IN INDIVIDUALS IN NEED OF TREATMENT FOR ACUTE URTICARIA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,513,259
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010266103 | ⤷ Sign Up | |||
| Canada | 2803987 | ⤷ Sign Up | |||
| European Patent Office | 2477634 | ⤷ Sign Up | |||
| Spain | 2616703 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2011003074 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
